Tiziana Life Sciences Ltd./$TLSA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
Ticker
$TLSA
Sector
Primary listing
Employees
9
Headquarters
Website
TLSA Metrics
BasicAdvanced
$166M
-
-$0.11
-
-
Price and volume
Market cap
$166M
52-week high
$2.60
52-week low
$0.73
Average daily volume
132K
Financial strength
Current ratio
1.719
Quick ratio
1.649
Total debt to equity
1.163
Profitability
EBITDA (TTM)
-18.464
Effective tax rate (TTM)
10.81%
Management effectiveness
Return on assets (TTM)
-83.78%
Return on equity (TTM)
-232.31%
Valuation
Price to book
16.79
Price to tangible book (TTM)
16.79
Price to free cash flow (TTM)
-16.849
Free cash flow yield (TTM)
-5.94%
Free cash flow per share (TTM)
-0.077
Growth
Earnings per share change (TTM)
-15.24%
3-year earnings per share growth (CAGR)
2.65%
10-year earnings per share growth (CAGR)
-3.29%
TLSA News
AllArticlesVideos
Tiziana reports biomarker gains for nasal MS therapy in progressive disease
Proactive Investors·3 weeks ago
Tiziana Life Sciences publishes positive study on intranasal MS therapy
Proactive Investors·2 months ago
Tiziana Life Sciences announces closing of oversubscribed $8.8M offering
Proactive Investors·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tiziana Life Sciences Ltd. stock?
Tiziana Life Sciences Ltd. (TLSA) has a market cap of $166M as of March 20, 2026.
What is the P/E ratio for Tiziana Life Sciences Ltd. stock?
The price to earnings (P/E) ratio for Tiziana Life Sciences Ltd. (TLSA) stock is 0 as of March 20, 2026.
Does Tiziana Life Sciences Ltd. stock pay dividends?
No, Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders as of March 20, 2026.
When is the next Tiziana Life Sciences Ltd. dividend payment date?
Tiziana Life Sciences Ltd. (TLSA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tiziana Life Sciences Ltd.?
Tiziana Life Sciences Ltd. (TLSA) does not currently have a Beta indicator.